Educational Background

Yonsei University College of Medicine, MD, PhD

Professional Career

Associate Professor, Chief, Division of Pediatric Cardiology, Yonsei University College of Medicine

Fellow of the European Society of Cardiology (FESC)

Fellow of the American College of Cardiology (FACC)

Academic Committee Member of Korean Pulmonary Hypertension Society

Research Field

Congenital heart disease

Adult congenital heart disease

Pharmacovigiance study using WHO VigiBase database

Translational research
1. Computer fluid dynamics
2. Pulmonary arterial hypertension including nitric oxide inhalation delivery

Papers, Books, etc. presented or published by your name

1. Y. Oh, K. Park, S. Jung, M. Y.-H. Kim, S. Y. Jung*, J. Hong et al. Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment. Small 2023, 2308936.

2. W. Choi, M. Choi, T. Jun, S. Lee, S. Y. Jung*, J. Hong et al. Templated Assembly of Silk Fibroin for a Bio-Feedstock-Derived Heart Valve Leaflet. Adv. Funct. Mater. 2023, 2307106.

3. SW Jung, SE Heo, YG Oh, YH Kim, SY Jung*, JK Hong et al. Zwitterionic Inhaler with Synergistic Therapeutics for Reprogramming of M2 Macrophage to Pro-Inflammatory Phenotype. Adv. Healthcare Mater.2023, onlie first

4. Choi M, Choi W, Hwang PTJ, Oh Y, Jun T, Ryu DY, Kim NK, Jang EH, Shin YR, Youn YN, Lee SH, Jung SY, Hong J. Engineered silk fibroin bio-hybrid artificial graft with releasing biological gas for enhanced circulatory stability and surgical performance. Int J Biol Macromol. 2025 May;309(Pt 2):142760.

5. Jung SY, Jung D, Kim AY, Seol JH, Park JM, Jung JW, et al. Selexipag as Add-on Therapy for Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: A Single-Center Retrospective Study. Congeni Heart Dis. 2021;16(3):233–244.

Educational Background

1999 – 2005 Bachelor degree from Keimyung University, School of Medicine, Daegu, Korea

2006 – 2008 Master of Science from Keimyung University, Graduate School, Daegu, Korea

2009 – 2014 Ph.D. degree from Keimyung University, Graduate School, Daegu, Korea

Professional Career

2016.3 ~ 2017.2 Assistant Professor, Division of Cardiology, Severance Cardiovascular Hospital

2017.3 ~ 2021.2 Assistant Professor, Keimyung University Dongsan Hospital

2022.7 ~ 2023.7 Visiting Professor, Heart Transplant Program, Smidt Heart Institute Cedars-Sinai Medical Center, Los Angeles, California

2021.3 ~ Present Associate Professor, Keimyung University Dongsan Hospital

Research Field

Heart Failure

Echocardiography

Pulmonary Hypertension

Hypertension

Transplantation

Papers, Books, etc. presented or published by your name

Ten-year follow-up cohort of the everolimus versus azathioprine multinational prospective study focusing on intravascular ultrasound findings. J Heart Lung Transplant. 2024

Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation. JACC Heart Fail. 2024 Feb;12(2):395-405

Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy. Sci Rep. 2022 May 11;12(1)

Educational Background

1998-2004 Pusan National University, College of Medicine, Medicine, Bachelor

2005～2007 Pusan National University, College of Medicine, Internal medicine, MMed

2012~2013 Pusan National University, College of Medicine, Internal medicine, Ph.D.

Professional Career

Feb 2004 Korean Medical License (No. 82164)

Mar 2009 Korean Board of Internal Medicine (No. 11607)

Oct 2015 Korean Subspecialty Board of Cardiology (No. 2-15-1019)

Mar 2021~ present: Assistant Professor, Internal Medicine (Division of Cardiology), Pusan National University Yangsan Hospital, Yangsan, Korea

Research Field

Echocardiography,

Pulmonary Hypertension,

Hypertension / Dyslipidemia,

Cardiac amyloidosis / Cardiac Sarcoidosis

Papers, Books, etc. presented or published by your name

1. Value of Coronary Angiography in the Cardiac Myxoma. Clin Anat. 2019 Nov 21. doi: 10.1002/ca.23527

2. Mitral Loop Cerclage Annuloplasty for Secondary Mitral Regurgitation: First Human Results. JACC Cardiovasc Interv. 2017 Mar 27;10(6):597-610

3. Prognostic Significance of Presenting Blood Pressure in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Am J Hypertens. 2015 Jun;28(6):797-805.

4. Right Cardiac Catheterization Using the Antecubital Fossa Vein in Korean Patients. Korean Circ J. 2016 Mar;46(2):207-12.

Educational Background

M.D., School of Chinese Medicine (double major in Medicine), China Medical University, Taichung, Taiwan

M.Sc., Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan

Ph.D., Bristol Heart Institute, University of Bristol, Bristol, United Kingdom

Professional Career

2006- Senior Consultant Cardiologist, Department of Cardiovascular Medicine, MacKay Memorial Hospital, Taipei, Taiwan

2016-2023 Chair, Department of Medicine, MacKay Medical College, New Taipei, Taiwan

2016-2023 Chief, Department of Medical Education, MacKay Memorial Hospital, Taipei, Taiwan

2024- High Commissioner, Superintendent Office, MacKay Memorial Hospital, Taipei, Taiwan

2024- Chief, Division of Preventive Cardiology & Pulmonary Circulation Medicine, Department of Cardiovascular Medicine, MacKay Memorial Hospital, Taipei, Taiwan

Research Field

1. Vascular biology

2. Pulmonary hypertension

3. Endothelial progenitor cells

4. Medical education

Papers, Books, etc. presented or published by your name

1. Wu YJ, Bond M, Sala-Newby GB, Newby AC. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ Res 2006;98:1141-50.

2. Bond M*, Wu YJ*, Sala-Newby GB, Newby AC. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation and intima formation in vitro and in vivo. Cardiovasc Res 2008;80:290-8.

3. Wang HH, Lee YN, Su CH, Shu KT, Liu WT, Hsieh CL, Yeh HI, Wu YJ*. S-phase kinase-associated protein-2 rejuvenates senescent endothelial progenitor cells and induces angiogenesis in vivo. Sci Rep 2020;10(1):6646.

4. Lee YN, Wang HH, Su CH, Lee HI, Chou YH, Hsieh CL, Liu WT, Shu KT, Chang KT, Yeh HI, Wu YJ*. Deferoxamine accelerates endothelial progenitor cell senescence to compromise angiogenic activity. Aging 2021;13(17):21364-21384.

5. Chou YH, Lee YN, Su CH, Lee HI, Hsieh CL, Tien TY, Lin CF, Yeh HI, Wu YJ*. Senescence induces miR-409 to down-regulate CCL5 and impairs angiogenesis in endothelial progenitor cells. J Cell Mol Med 2024;24(12):e18489.

Educational Background

PhD, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea

MSc, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea

MD, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea

Professional Career

Apr 2024 – Present; Professor, Division of Cardiology, Uijeonbu St. Mary’s Hospital, The Catholic University of Korea

Mar 2019 - Mar 2024; Professor, Division of Cardiology, Seoul St. Mary’s Hospital, The Catholic University of Korea

March 2012 - Aug 2013; Postdoctoral Research Fellow, Division of Cardiology, Emory University, Atlanta, GA, USA

Research Field

Cardiology, Interventional

Acute Myocardial Infarction, Heart failure

Cardiovascular regenerative medicine

Papers, Books, etc. presented or published by your name

1) Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy. Nat Commun. 2024;15:8481, Role: Corresponding author

2) Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications. Nat Commun. 2024;15:2564. Role: Corresponding author

3) Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease. Cardiovasc Res. 2024 25;120:1737-1751. Role: Corresponding author

4) Hyaluronic acid stimulation of stem cells for cardiac repair: a cell-free strategy for myocardial infarct. J Nanobiotechnology. 2024;22:149. Role: Corresponding author

5) Robust and customizable spheroid culture system for regenerative medicine. Biofabrication. 2024 2;16 Role: Corresponding author